NDA 050599

LILLY

FDA Drug Application

Application #050599

Application Sponsors

NDA 050599

LILLY

Marketing Status

• Discontinued: 001

Application Products

001

SUSPENSION;ORAL

EQ 125MG BASE/5ML;EQ 600MG BASE/5ML

0

ILOSONE SULFA

ERYTHROMYCIN ESTOLATE; SULFISOXAZOLE ACETYL

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 50599
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)